Submit Manuscript  

Article Details


The Role of Peroxisome Proliferator-Activated Receptor in Addiction: A Novel Drug Target

[ Vol. 21 , Issue. 11 ]

Author(s):

Carla Quiroga, Juan José Barberena, Jocelyne Alcaraz-Silva , Sérgio Machado, Claudio Imperatori , Ali Yadollahpour , Henning Budde, Tetsuya Yamamoto, Diogo Telles-Correia and Eric Murillo-Rodríguez *   Pages 964 - 975 ( 12 )

Abstract:


The peroxisome proliferator activated receptors (PPARs) are a superfamily of well-recognized ligand-binding nuclear receptors comprising three isoforms: PPARα, PPARγ, and PPARβ/δ. In response to endogenous lipid messengers, PPARs trigger the transcription of genes related to a wider spectrum of physiological phenomena, including fatty acid oxidation, inflammation, adipogenesis, among many others. Thus, the importance of PPARs as putative protective therapy in health issues has increased the interest of studying these nuclear receptors, including the management of neurodegenerative disorders, multiple sclerosis, and likely addiction. In recent years, several pieces of evidence from animal models have demonstrated the promising role of PPARs as a critical element for interventions in addictive behaviors by reducing the reinforcing properties of addictive substances such as alcohol. However, there is a lack of data in the scope and has so far been unexplored the function of PPARs in additional drugs such as cannabis, opioids, methamphetamine, or cocaine. A similar scenario has been found for the management of binge-type eating disorders. Thus, here we review recent advances in understanding the relevance of the PPAR controlling addiction.

Keywords:

Alcohol, Cannabis, Nicotine, Sleep, Therapy, PPARs.

Affiliation:

Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medicina, Division Ciencias de la Salud, Universidad Anahuac Mayab, Merida, Yucatan, Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medicina, Division Ciencias de la Salud, Universidad Anahuac Mayab, Merida, Yucatan, Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medicina, Division Ciencias de la Salud, Universidad Anahuac Mayab, Merida, Yucatan, Intercontinental Neuroscience Research Group, Intercontinental Neuroscience Research Group, Department of Psychology, University of Sheffield, Sheffield, Intercontinental Neuroscience Research Group, Intercontinental Neuroscience Research Group, Faculty of Medicine, University of Lisbon, Lisbon, Laboratorio de Neurociencias Moleculares e Integrativas, Escuela de Medicina, Division Ciencias de la Salud, Universidad Anahuac Mayab, Merida, Yucatan

Graphical Abstract:



Read Full-Text article